Holen Sie sich die Stockscreener-App
0.3702
4.61%
-0.0178
Schlusskurs vom Vortag:
$0.388
Offen:
$0.4
24-Stunden-Volumen:
616.94K
Relative Volume:
0.07
Marktkapitalisierung:
$2.55M
Einnahmen:
$52.63M
Nettoeinkommen (Verlust:
$-8.12M
KGV:
-0.0297
EPS:
-12.45
Netto-Cashflow:
$-42.02M
1W Leistung:
-39.33%
1M Leistung:
-50.65%
6M Leistung:
-72.79%
1J Leistung:
-92.32%
1-Tages-Spanne:
$0.361
$0.40
1-Wochen-Bereich:
$0.361
$0.62
52-Wochen-Spanne:
$0.295
$5.37
Molecular Templates Inc Stock (MTEM) Company Profile
Firmenname
Molecular Templates Inc
Sektor
Branche
Telefon
512 896 1555
Adresse
9301 AMBERGLEN BLVD, AUSTIN, TX
Vergleichen Sie MTEM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| MTEM | 0.3701 | 2.55M | 52.63M | -8.12M | -42.02M | -12.45 |
| VRTX | 450.30 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.35 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.34 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Molecular Templates Inc Stock (MTEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-04-21 | Eingeleitet | BofA Securities | Buy |
| 2021-02-01 | Eingeleitet | UBS | Neutral |
| 2020-09-08 | Eingeleitet | Jefferies | Buy |
| 2020-03-25 | Eingeleitet | Stifel | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-04-29 | Eingeleitet | UBS | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-10-08 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Molecular Templates Inc Aktie (MTEM) Neueste Nachrichten
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.47% - MSN
BB Biotech AG's Strategic Acquisition in Molecular Templates Inc - GuruFocus.com
Bb Biotech sells $845,833 in Molecular Templates shares - Investing.com India
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT)’s Stock Reduces -12.58%, Making It A Good Investment - Stocks Register
Analysts Predict Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) To Loss -577.97% From Current Levels. - Stocks Register
Molecular Templates Inc (NASDAQ: MTEM) Drops -23.41 Percent In Recent Session, Why Are You Interested? - Stocks Register
Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
United States shares lower at close of trade; Dow Jones Industrial Average down 0.47% - Investing.com India
Stock Market Movers Today • Top Gainers & Losers - Benzinga
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
Agenus (AGEN) Stock Dips Amid Financial Performance and Industry Trends - GuruFocus.com
U.S. STOCKS Talen Energy, Biogen, Ovintiv - XM
U.S. Stock market: Molecular Templates surges by 155.81% while Sow Good declines by 53.39% during mid day trading - Business Upturn
Austin InnoProper Good heads to the big box | Austin startups on the Deloitte Fast 500 - The Business Journals
Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion - cnhinews.com
Clairity Appoints Jeffrey R. Luber as CEO - citybiz
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - MSN
In-vitro Transcription Templates Market to Witness Robust Growth at 19.53% CAGR by 2031 - WhaTech
Bitdeer Technologies Holding Co (NASDAQ: BTDR) Is The Number One Stock Currently Moving. - Stocks Register
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - Benzinga
Global Leukemia Therapeutics Market Overview And Statistics For 2024-2033 - EIN News
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.37% - MSN
Wall Street-Heavily Traded - WDRB
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Biotech Alert: Searches spiking for these stocks today - TipRanks
why Molecular Templates Inc [MTEM] is a Good Choice for Investors After New Price Target of $18.00 - The DBT News
Closing Bell Recap: Molecular Templates Inc (MTEM) Ends at 0.39, Reflecting a -73.48 Downturn - The Dwinnex
United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
MTEM stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa
MTEM stock touches 52-week low at $0.31 amid market challenges - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - Benzinga
A closer look at MTEM’s price-to-free cash flow ratio - US Post News
Molecular Templates Inc (MTEM) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher - Benzinga
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction - Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket - Benzinga
Stocks to Watch: Boeing, Vera Bradley, Molecular Templates - Morningstar
Molecular Templates dips after board approves liquidation plan - XM
Finanzdaten der Molecular Templates Inc-Aktie (MTEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Molecular Templates Inc-Aktie (MTEM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BIOTECH TARGET N V | 10% Owner |
Apr 02 '24 |
Buy |
2.35 |
250,000 |
587,500 |
1,279,820 |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):